Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
Ann Hematol
; 98(6): 1435-1440, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-30874850
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Salvage Therapy
/
Antineoplastic Agents, Immunological
/
Antibodies, Monoclonal
/
Multiple Myeloma
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
France
Country of publication:
Germany